| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |